Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03137355 · ClinicalTrials.gov registry record
The International Registry for Leigh Syndrome
A clinical trial of Leigh Syndrome and Leigh Disease, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03137355: Recruiting study of Leigh Syndrome and Leigh Disease, sponsored by The University of Texas Health Science Center, Houston.
NCT03137355 is a study of Leigh Syndrome and Leigh Disease that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03137355, a study of Leigh Syndrome and Leigh Disease, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a database containing clinical and laboratory information for patients with Leigh syndrome. The goal is to provide a greater understanding of Leigh syndrome allowing further characterization of this disease.
Primary Outcome
The goal of this project is to collect longitudinal data on the natural history of Leigh syndrome.
Conditions Studied
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-06-17 |
| Est. Completion | 2030-06-17 |
What NCT03137355 shows while recruiting
NCT03137355 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 5 conditions, with Leigh Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03137355 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03137355 about?
NCT03137355 is a clinical study titled "The International Registry for Leigh Syndrome". The purpose of this study is to develop a database containing clinical and laboratory information for patients with Leigh syndrome. The goal is to provide a greater understanding of Leigh syndrome allowing further characterization of this disease.
What is the current status of trial NCT03137355?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2015-06-17. Estimated completion is 2030-06-17.
What conditions does trial NCT03137355 study?
This clinical trial studies the following conditions: Leigh Syndrome, Leigh Disease, Leigh's Necrotizing Encephalopathy, Subacute Necrotizing Encephalomyopathy, Subacute Necrotizing Encephalomyelopathy.
Who is sponsoring clinical trial NCT03137355?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03137355 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leigh Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI